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Abstract
Introduction: The climate change and global warming/
ice age results in endosymbiotic actinidic archaeal 
growth in the human system and cholesterol catabolism 
resulting in endogenous digoxin synthesis. The increased 
endosymbiotic archaeal growth detected in autism and 
matrilineal communities with increased incidence of 
autism and neanderthalic origin leads to the conclusion 
that digoxin acts as neanderthalic hormone. The increased 
endosymbiotic archaeal growth and resultant endogenous 
digoxin synthesis in relation to climate change and global 
warming results in neanderthalisation of homo sapiens 
and human disease resulting in homo sapien extinction. 
Digoxin can inhibit reverse transcriptase activity and 
RNA editing resulting in suppression of endogenous 
retroviral growth. This produces inhibition of HERV 
expression and jumping gene phenomena producing in 
adynamicity of the human genome. HERV related jumping 
genes are crucial in synaptic diversity, HLA expression 
and immunomodulation as well as metabolic diversity. 
Digoxin produces alteration in sodium-hydrogen exchange 
producing an acidic pH and acts like a growth factor 
producing stem cell transformation of adult cells. Stem 
cells have a distinct metabolism with increased glycolysis 
and suppression of PDH and mitochondrial function. This 
can result in cancer and metabolic syndrome. The digoxin 
interference with RNA editing can lead to mutated RNA 
viruses and wide spread RNA viral epidemics. The 
digoxin interference with HERV expression and RNA 
editing and resultant inhibition of genomic, metabolic, 
neural and immune diversity produces autoimmune 
disease, cancer, metabolic syndrome, degenerations, 
schizophrenia and autism which are increasing at 
epidemic rates in human population. 
Materials and Methods: Endogenous digoxin levels and 
serum cytochrome F420 levels as a marker of archaeal 
growth were estimated in matrilineal communities, SLE, 
multiple sclerosis, parkinson’s disease, alzheimer’s 
disease, CNS glioma, multiple myeloma, metabolic 
syndrome x with CAD and CVA, schizophrenia and 
autism. 15 numbers were included in each group and each 
patient had an age and sex matched control. Endogenous 
digoxin was estimated by Elisa and cytochrome F420 
estimated by spectrophotometry. The statistical analysis 
was done by ANOVA.
Results: Endogenous digoxin levels and cytochrome 
F420 levels were elevated in matrilineal neanderthalic 
communities, SLE, multiple sclerosis, parkinson’s disease, 
alzheimer’s disease, CNS glioma, multiple myeloma, 
metabolic syndrome x with CAD and CVA, schizophrenia 
and autism. Endogenous digoxin and cytochrome F420 
levels were low in non-matrilineal homo sapien population. 
Conclusion: Homo sapiens tend to have low levels of 
endosymbiotic actinidic archaea and low digoxin synthesis. 
Homo sapiens have low incidence of autoimmune disease, 
cancer, schizophrenia, autism and metabolic syndrome. 
The neanderthalisation of homo sapiens consequent to 
endosymbiotic actinidic archaeal growth and digoxin 
synthesis produces human pathology and extinction. 
Homo neanderthalis have higher rates of actinidic archaeal 
symbiosis and digoxin synthesis with higher incidence of 
autoimmune disease, cancer, schizophrenia, autism and 
metabolic syndrome. Actinidic archaeal secreted digoxin 
functions as a Neanderthal hormone. 
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INTRODUCTION
The climate change and global warming/ice age results 
in endosymbiotic actinidic archaeal growth in the 
human system and cholesterol catabolism resulting 
in endogenous digoxin synthesis.  The increased 
endosymbiotic archaeal growth detected in autism and 
matrilineal communities with increased incidence of 
autism and neanderthalic origin leads to the conclusion 
that digoxin acts as neanderthalic hormone. The increased 
endosymbiotic archaeal growth and resultant endogenous 
digoxin synthesis in relation to climate change and global 
warming results in neanderthalisation of homo sapiens 
and human disease resulting in homo sapien extinction. 
Digoxin can inhibit reverse transcriptase activity and RNA 
editing resulting in suppression of endogenous retroviral 
growth. This produces inhibition of HERV expression 
and jumping gene phenomena producing in adynamicity 
of the human genome. HERV related jumping genes 
are crucial in synaptic diversity, HLA expression and 
immunomodulation as well as metabolic diversity. 
Digoxin produces alteration in sodium-hydrogen exchange 
producing an acidic pH and acts like a growth factor 
producing stem cell transformation of adult cells. Stem 
cells have a distinct metabolism with increased glycolysis 
and suppression of PDH and mitochondrial function. This 
can result in cancer and metabolic syndrome. The digoxin 
interference with RNA editing can lead to mutated RNA 
viruses and wide spread RNA viral epidemics. The 
digoxin interference with HERV expression and RNA 
editing and resultant inhibition of genomic, metabolic, 
neural and immune diversity produces autoimmune 
disease, cancer, metabolic syndrome, degenerations, 
schizophrenia and autism which are increasing at 
epidemic rates in human population. Homo sapiens tend 
to have low levels of endosymbiotic actinidic archaea and 
low digoxin synthesis. Homo sapiens have low incidence 
of autoimmune disease, cancer, schizophrenia, autism 
and metabolic syndrome. The neanderthalisation of homo 
sapiens consequent to endosymbiotic actinidic archaeal 
growth and digoxin synthesis produces human pathology 
and extinction.1-16
MATERIALS AND METHODS
Endogenous digoxin levels and serum cytochrome F420 
levels as a marker of archaeal growth were estimated 
in matrilineal communities, SLE, multiple sclerosis, 
parkinson’s disease, alzheimer’s disease, CNS glioma, 
multiple myeloma, metabolic syndrome x with CAD and 
CVA, schizophrenia and autism. 15 numbers were included 
in each group and each patient had an age and sex matched 
control. Endogenous digoxin was estimated by Elisa and 
cytochrome F420 estimated by spectrophotometry. The 
statistical analysis was done by ANOVA.
RESULTS
Endogenous digoxin levels and cytochrome F420 levels 
were elevated in matrilineal neanderthalic communities, 
SLE, multiple sclerosis, parkinson’s disease, alzheimer’s 
disease, CNS glioma, multiple myeloma, metabolic 
syndrome x with CAD and CVA, schizophrenia and 
autism. Endogenous digoxin and cytochrome F420 levels 
were low in non-matrilineal homo sapien population. 
Table 1
 Digoxin Levels
Group
Digoxin (ng/ml)
(increase with cerium)
Digoxin (ng/ml)
(decrease with 
doxy+cipro)
Mean + SD Mean + SD
Homo sapiens 0.11 0.00 0.054 0.003
Schizo 0.55 0.06 0.219 0.043
Autism 0.51 0.05 0.199 0.027
AD 0.55 0.03 0.192 0.040
MS 0.52 0.03 0.214 0.032
Glioma 0.54 0.04 0.210 0.042
DM 0.47 0.04 0.202 0.025
Myeloma 0.56 0.05 0.220 0.052
PD 0.53 0.06 0.212 0.045
Autism 0.53 0.08 0.205 0.041
Neanderthals 0.51 0.05 0.213 0.033
F value 135.116
P value < 0.001
F value 71.706
P value < 0.001
Table 2
Cytochrome F420 levels
Group
Cytochrome F420 %
(increase with cerium)
Mean + SD
Homo sapiens 4.48 0.15
Schizo 23.24 2.01
Autism 23.46 1.87
AD 23.12 2.00
MS 22.12 1.81
Glioma 22.79 2.13
DM 22.59 1.86
SLE 22.29 1.66
PD 22.06 1.61
Autism 21.68 1.90
Neanderthals 22.70 1.87
F value 306.749
P value < 0.001
DISCUSSION
The increased endosymbiotic archaeal growth detected 
in autism and matrilineal communities with increased 
incidence of autism and neanderthalic origin leads 
to the conclusion that digoxin acts as neanderthalic 
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hormone. The increased endosymbiotic archaeal 
growth and resultant endogenous digoxin synthesis in 
relation to climate change and global warming results in 
neanderthalisation of homo sapiens and human disease 
resulting in homo sapiens extinction. Homo sapiens tend 
to have low levels of endosymbiotic actinidic archaea and 
low digoxin synthesis. Homo sapiens have low incidence 
of autoimmune disease, cancer, schizophrenia, autism 
and metabolic syndrome. The neanderthalisation of homo 
sapiens consequent to endosymbiotic actinidic archaeal 
growth and digoxin synthesis produces human pathology 
and extinction. 
The climate change and global warming/ice age 
results in endosymbiotic actinidic archaeal growth in the 
human system and cholesterol catabolism resulting in 
endogenous digoxin synthesis. Cholesterol catabolism 
can produce endogenous digoxin synthesis. Endogenous 
digoxin can modulate RNA metabolism. Digoxin can 
inhibit reverse transcriptase activity and RNA editing 
resulting in suppression of endogenous retroviral growth. 
High endogenous digoxin levels can produce retroviral 
resistance. This produces inhibition of HERV expression 
and jumping gene phenomena producing in adynamicity 
of the human genome. HERV can act as jumping genes 
producing genomic dynamicity. HERV related jumping 
genes are crucial in synaptic diversity, HLA expression 
and immunomodulation as well as metabolic diversity. 
The digoxin interference with HERV expression and RNA 
editing and resultant inhibition of genomic, metabolic, 
neural and immune diversity produces autoimmune 
disease, cancer, metabolic syndrome, degenerations, 
schizophrenia and autism which are increasing at epidemic 
rates in human population. The HERV jumping genes 
produces changes in the genome resulting in synaptic 
diversity and neural network specialisation. The absence 
of HERV expression results in prefrontal cortex atrophy 
and cerebellar dominance. The cerebellum is supposed to 
have cognitive functions. Cerebellar dysfunction results 
in the cerebellar cognitive affective syndrome. Cerebellar 
dominance results in speech dysfunction and development 
of music and dance as a form of expression. Cerebellum 
in concerned with intuition and extra sensory perception. 
Cerebellum also mediates hypnotic trances and spiritual 
experiences. The cerebellum is concerned with impulsive 
behavior and the fear, flight, fight responses. Cerebellum 
is also the site of intuitive creativity. Cerebellum 
modulates our interaction with the internet. The resulting 
cerebellar dominance results in schizophrenia, autism, 
ADHD, addiction, criminality, autistic savant phenomena, 
introverted behavior and alternate sexuality. It results in an 
epidemic frontal lobe syndrome and cerebellar cognitive 
affective syndrome. The inhibition of HERV expression 
results in decreased diversity of HLA gene expression 
and autoimmune disease. There is increasing incidence of 
autoimmune disease in this century. 
Digoxin produces alteration in sodium-hydrogen 
exchange producing an acidic pH and acts like a 
growth factor producing stem cell transformation of 
adult cells. Stem cells have a distinct metabolism with 
increased glycolysis and suppression of PDH and 
mitochondrial function. The stem cell metabolonomics 
results in metabolic syndrome x and diabetes mellitus 
with increased incidence of CVA and CAD. Digoxin 
converts adult cells to the stem cells. The adult cells 
envelope is of archaeal origin. This results in regression to 
endosymbiotic archaeal state. The human body is reduced 
to archaeal colony network or zombie. The conversion 
to stem cells results in cellular proliferation and cancer. 
Cancer and metabolic syndrome x is rising in epidemic 
proportions in the present century. There is increased 
incidence of degenerations like alzheimer’s disease and 
parkinson’s disease. Increased digoxin can increase 
cellular calcium producing mitochondrial cell death by 
activating the caspase cascade. The conversion of adult 
cells to archaeal stem cells by endogenous digoxin can 
alter cellular metabolonomics and produce mitochondrial 
dysfunction resulting in degenerations. 
Global warming results in increased carbon dioxide 
the atmosphere, acidic pH and archaeal growth. Archaea 
are extremophiles. Neanderthalisation of homo sapiens 
is a symbiotic transformation due to archaeal growth. 
The increased endosymbiotic actinidic archaeal growth 
the human system as well as the conversion of adult 
cells to stem cells/archaeal forms of cells results in 
neanderthalisation of homo sapiens. This results in 
increased incidence of systemic diseases in homo sapiens 
and their extinction. The digoxin interference with RNA 
editing can lead to mutated RNA viruses and wide spread 
RNA viral epidemics. There is increased incidence of 
RNA viral epidemics in relation to global warming. H1N1 
epidemics, the SARS syndrome and increasing dengue 
epidemics are part of the phenomena. The RNA viral 
epidemics can result in homo sapiens extinction. The 
increased actinidic archaeal growth in the ocean beds 
releases methane which shifts the ocean continental crusts 
resulting in earthquakes and tsunamis. This can lead to 
widespread catastrophies and extinction of homo sapiens 
human population as such. This phenomenon is inevitable 
as the homo sapiens civilisation expands and technology 
grows. The increased production of greenhouse gases as 
a part of civilisational growth leads to global warming, 
actinidic archaeal growth, neanderthalisation of humans 
and archaeal related oceanic tsunamis and earthquakes 
resulting in catastrophic human extinction. This can be 
described as the Cassandra hypothesis. 
Homo sapiens tend to have low levels of endosymbiotic 
actinidic archaea and low digoxin synthesis. Homo 
sapiens have low incidence of autoimmune disease, 
cancer, schizophrenia, autism and metabolic syndrome. 
The neanderthalisation of homo sapiens consequent to 
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endosymbiotic actinidic archaeal growth and digoxin 
synthesis produces human pathology and extinction. 
Homo neanderthalis have higher rates of actinidic archaeal 
symbiosis and digoxin synthesis with higher incidence of 
autoimmune disease, cancer, schizophrenia, autism and 
metabolic syndrome. Actinidic archaeal secreted digoxin 
functions as a Neanderthal hormone. 
 The extinction of homo neanderthalis  could 
be attributed to archaeal synthesised compounds 
including digoxin. The archaeal digoxin can regulate 
the nervous system including the NMDA/GABA 
thalamocorticothalamic pathway mediating conscious 
perception. NMDA/GABA receptors  can  be modulated 
by digoxin induced calcium oscillations resulting NMDA/
GAD activity induction. The dipolar PAH and archaeal 
magnetite  in the setting of digoxin induced sodium 
potassium ATPase inhibition can produce a pumped 
phonon system mediated  frohlich model superconducting 
state inducing quantal perception with nanoarchaeal sensed 
gravity producing the orchestrated reduction of the quantal 
possibilities to the macroscopic world. The higher degree 
of integration of the archaea into the genome produces 
increased digoxin synthesis producing right hemispheric 
dominance and lesser degree producing left hemispheric 
dominance. The increased integration of archaea into the 
neuronal genome can produce increased digoxin mediated 
NMDA transmission producing schizophrenia and autism. 
Digoxin induced calcium oscillations can activate NFKB 
producing immune activation and cytokine secretion. The 
archaeal digoxin induced chronic immune activation can 
lead on to autoimmune disease.  Archaeal digoxin can 
induce the host AKT PI3K, AMPK, HIF alpha and NFKB 
producing the Warburg metabolic phenotype. There 
is induction of glycolysis, inhibition of PDH activity 
and mitochondrial dysfunction resulting in inefficient 
energetics and metabolic syndrome. The archaeal digoxin 
generated cytokines can lead to TNF alpha induced 
insulin resistance and metabolic syndrome x. Digoxin 
induced sodium potassium ATPase inhibition can lead to 
increase in HMG CoA reductase activity and increased 
cholesterol synthesis. The increased cholesterol substrate 
also leads to increased archaeal growth and digoxin 
synthesis due to metabolic channeling to the mevalonate 
pathway. Digoxin can produce sodium-potassium ATPase 
inhibition and inward movement of plasma membrane 
cholesterol. This produces defective SREBP sensing, 
increased HMG CoA reductase activity and cholesterol 
synthesis. The digoxin induced inward movement of 
plasma membrane cholesterol can alter membrane 
cholesterol/sphingomyelin ratio producing modified lipid 
microdomains. The digoxin induced lipid microdomain 
modulation can regulate the GPCR couple adrenaline, 
noradrenaline, glucagon and neuropeptide receptors as 
well as protein tyrosine kinase linked insulin receptor. The 
digoxin mediated inhibition of nuclear membrane sodium-
potassium ATPase can modulate nuclear membrane lipid 
microdomains and steroidal/thyroxine DNA receptor 
function. Thus endogenous digoxin can modulate all the 
endocrine receptors by regulating lipid microdomains. 
Hyperdigoxinemia is important in the pathogenesis 
of atherogenesis and metabolic syndrome X. Digoxin 
induced sodium-potassium ATPase inhibition results in an 
ATP sparing effect. Eighty percent of the ATP generated 
is used to run the sodium-potassium ATPase pump. The 
digoxin inhibition of the sodium-potassium ATPase spares 
this ATP which is then used for lipid synthesis. Thus 
endogenous digoxin and the shadow biosphere generated 
Warburg phenotype can produce increased lipid synthesis 
and obesity important in metabolic syndrome X. Fat 
fuels insulin resistance by binding to the toll receptor and 
producing immune activation and immune infiltration 
of the adipose tissue. The archaeal digoxin induced 
monocyte activation and Warburg phenotype induced 
increased cholesterol synthesis leads to atherogenesis. The 
Warburg phenotype induced increased mitochondrial PT 
pore hexokinase can lead on to malignant transformation. 
The digoxin induced increased intracellular calcium can 
lead to PT pore dysfunction, cell death and neuronal 
degeneration. The digoxin mediated transcribed HERV 
RNA can get encapsulated in microvesicles contributing 
to the retroviral state. The prion protein conformation 
is modulated by HERV RNA binding producing prion 
disease. The archaeal digoxin and rutile induced 
magnesium depletion can lead MPS deposition and 
produce EMF, CCP, MNG and mucoid angiopathy. 
Thus the archaeal digoxin can produce neuro-immune-
metabolic-endocrine-genetic integration. The increased 
archaeal cholesterol catabolism and digoxin secretion 
can lead to diverse pathological states of neuronal 
degeneration, metabolic syndrome X, autoimmune 
disease, malignancy and psychiatric disorders. Thus 
the archaeal synthesised compounds would have led to 
neanderthalisation of homo sapiens and their eventual 
extinction and death of these great civilisations. 
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